BNP Paribas Financial Markets Lowers Holdings in Liquidia Co. (NASDAQ:LQDA)

BNP Paribas Financial Markets reduced its position in shares of Liquidia Co. (NASDAQ:LQDA - Free Report) by 38.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 86,882 shares of the company's stock after selling 53,308 shares during the period. BNP Paribas Financial Markets owned 0.10% of Liquidia worth $1,022,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Corebridge Financial Inc. increased its position in Liquidia by 2.3% during the fourth quarter. Corebridge Financial Inc. now owns 31,516 shares of the company's stock worth $371,000 after purchasing an additional 694 shares during the last quarter. Catalina Capital Group LLC increased its position in Liquidia by 6.5% during the fourth quarter. Catalina Capital Group LLC now owns 18,307 shares of the company's stock worth $215,000 after purchasing an additional 1,125 shares during the last quarter. Summit Investment Advisors Inc. increased its position in Liquidia by 35.0% during the fourth quarter. Summit Investment Advisors Inc. now owns 6,632 shares of the company's stock worth $78,000 after purchasing an additional 1,719 shares during the last quarter. Sigma Planning Corp increased its position in Liquidia by 3.4% during the fourth quarter. Sigma Planning Corp now owns 65,210 shares of the company's stock worth $767,000 after purchasing an additional 2,115 shares during the last quarter. Finally, DMC Group LLC increased its position in Liquidia by 17.4% during the fourth quarter. DMC Group LLC now owns 16,302 shares of the company's stock worth $192,000 after purchasing an additional 2,419 shares during the last quarter. 64.54% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. Oppenheimer set a $13.00 price objective on shares of Liquidia and gave the stock an "underperform" rating in a research report on Monday. Needham & Company LLC reaffirmed a "buy" rating and set a $25.00 target price on shares of Liquidia in a research note on Wednesday. HC Wainwright reaffirmed a "buy" rating and set a $29.00 target price on shares of Liquidia in a research note on Monday, May 12th. Scotiabank reaffirmed an "outperform" rating on shares of Liquidia in a research note on Monday, May 5th. Finally, Raymond James increased their target price on shares of Liquidia from $27.00 to $29.00 and gave the stock a "strong-buy" rating in a research note on Friday, May 9th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, six have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $25.56.

Insider Activity at Liquidia

In other news, CEO Roger Jeffs sold 14,130 shares of Liquidia stock in a transaction on Monday, April 14th. The shares were sold at an average price of $13.57, for a total value of $191,744.10. Following the transaction, the chief executive officer now directly owns 1,006,420 shares of the company's stock, valued at $13,657,119.40. The trade was a 1.38% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Jason Adair sold 1,856 shares of Liquidia stock in a transaction on Monday, April 14th. The shares were sold at an average price of $13.57, for a total transaction of $25,185.92. Following the completion of the transaction, the insider now directly owns 184,304 shares in the company, valued at $2,501,005.28. The trade was a 1.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,138 shares of company stock valued at $450,233 over the last 90 days. 26.50% of the stock is owned by corporate insiders.

Liquidia Price Performance

Shares of NASDAQ LQDA traded down $0.21 during midday trading on Friday, hitting $15.35. The company's stock had a trading volume of 4,742,122 shares, compared to its average volume of 1,065,159. The business's fifty day simple moving average is $14.74 and its two-hundred day simple moving average is $13.57. Liquidia Co. has a 1 year low of $8.26 and a 1 year high of $19.41. The firm has a market capitalization of $1.31 billion, a price-to-earnings ratio of -9.42 and a beta of 0.24.

Liquidia (NASDAQ:LQDA - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported ($0.45) EPS for the quarter, missing the consensus estimate of ($0.42) by ($0.03). Liquidia had a negative net margin of 765.38% and a negative return on equity of 163.21%. The business had revenue of $3.12 million during the quarter, compared to analysts' expectations of $3.23 million. Analysts anticipate that Liquidia Co. will post -1.51 EPS for the current fiscal year.

Liquidia Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).